Less Ads, More Data, More Tools Register for FREE

Pin to quick picksInvestec Regulatory News (INVP)

Share Price Information for Investec (INVP)

Share Price is delayed by 15 minutes
Get Live Data
626.50    8.50 (1.38%)
Bid:
624.00
Ask:
625.00
Spread: 1.00 (0.16%)
Market Cap: £3.96b
INVP Live PriceLast checked at - London Stock Exchange

Intraday Investec Share Chart

Voluntary Shareholder update

5 Aug 2025 13:00

RNS Number : 0712U
Investec PLC
05 August 2025
 

Investec LimitedIncorporated in the Republic of South AfricaRegistration number 1925/002833/06JSE share code: INL

JSE hybrid code: INPR

JSE debt code: INLV

NSX share code: IVD

BSE share code: INVESTEC

ISIN: ZAE000081949

LEI: 213800CU7SM6O4UWOZ70

Investec plc

Incorporated in England and Wales

Registration number 3633621

LSE share code: INVP

JSE share code: INP

ISIN: GB00B17BBQ50

LEI: 2138007Z3U5GWDN3MY22

 

 

As part of the dual listed company structure, the boards of Investec plc and Investec Limited (together the "Board") notify both the London Stock Exchange and the JSE Limited of matters which are required to be disclosed under the Disclosure Guidance and Transparency Rules, and Listing Rules of the Financial Conduct Authority (the "FCA") and/or the JSE Listings Requirements.

 

Voluntary shareholder update

 

Investec welcomes the clarity provided by the Supreme Court of England and Wales' (the "Supreme Court") judgment on the appeal against the Court of Appeal's decision in Wrench, Hopcraft and Johnson concerning the payment of finance commission by motor finance lenders to motor dealers acting as credit brokers, which was handed down on 1 August 2025.

 

In establishing the provision estimate of £30mn, the Group created a number of scenarios to address uncertainties around a number of key assumptions. These included the potential outcomes of the UK Supreme Court appeal, any steps that the UK Financial Conduct Authority ("FCA") may take and outcomes in relation to the extent of harm and remedies. Other key assumptions included applicable commission models, commission rates, time periods, response rates, uphold rates, levels of redress/interest applied and costs to deliver. Whilst the judgment announced on 1 August provides additional clarity, there remain a number of uncertainties.

 

The FCA announced that it will publish a consultation on an industry wide redress scheme by early October 2025. The provision will continue to be reviewed as and when further information becomes available.

 

Following the initial assessment of the Supreme Court judgment and pending resolution of the outstanding uncertainties, in particular the FCA redress scheme, Investec believes that the current provision remains adequate.

 

Shareholders are advised that this voluntary update is based on financial information that has not

been reviewed and reported on by the group's external auditors.

 

London and Johannesburg

5 August 2025

 

Sponsor

Investec Bank Limited

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCPAMBTMTBMBPA
Date   Source Headline
7th Feb 20258:25 amGNWForm 8.5 (EPT/RI) - Dowlais Group plc
7th Feb 20258:17 amGNWForm 8.5 (EPT/RI) - Thruvision Group plc
7th Feb 20258:12 amGNWForm 8.5 (EPT/RI) - De La Rue plc
7th Feb 20258:06 amGNWForm 8.5 (EPT/RI)-Alliance Pharma plc
6th Feb 202511:02 amGNWForm 8.5 (EPT/RI)-Alliance Pharma plc
6th Feb 202510:54 amGNWForm 8.5 (EPT/RI)-Dowlais Group plc
5th Feb 20259:31 amGNWForm 8.5 (EPT/RI) - De La Rue plc
5th Feb 20259:26 amGNWForm 8.5 (EPT/RI) - Dowlais Group Plc
5th Feb 20259:20 amGNWForm 8.5 (EPT/RI)- Alliance Pharma plc
4th Feb 20259:02 amGNWForm 8.5 (EPT/RI) - Dowlais Group Plc
4th Feb 20258:54 amGNWForm 8.5 (EPT/RI) - De La Rue plc
4th Feb 20258:48 amGNWForm 8.5 (EPT/RI) - Alliance Pharma plc
3rd Feb 202511:15 amGNWForm 8.5 (EPT/RI) - Dowlais Group Plc
3rd Feb 202511:11 amGNWForm 8.5 (EPT/RI) - De La Rue plc
3rd Feb 202511:08 amGNWForm 8.5 (EPT/RI) - Alliance Pharma plc
31st Jan 20259:48 amGNWForm 8.5 (EPT/RI) - Alliance Pharma plc
31st Jan 20259:42 amGNWForm 8.5 (EPT/RI) - De La Rue plc
31st Jan 20259:38 amGNWForm 8.5 (EPT/RI) - Dowlais Group Plc
30th Jan 20253:00 pmRNSPublication of Suppl.Prospcts EMTN Programme
30th Jan 202512:22 pmGNWForm 8.5 (EPT/RI) - Dowlais Group Plc
30th Jan 202510:58 amGNWForm 8.5 (EPT/RI) - Thruvision Group plc
30th Jan 202510:55 amGNWForm 8.5 (EPT/RI) - De La Rue plc
30th Jan 202510:48 amGNWForm 8.5 (EPT/RI) - Alliance Pharma plc
29th Jan 20258:33 amGNWForm 8.5 (EPT/RI) - De La Rue plc
29th Jan 20258:29 amGNWForm 8.5 (EPT/RI) - Alliance Pharma plc
28th Jan 20258:20 amGNWForm 8.5 (EPT/RI) - Alliance Pharma plc
28th Jan 20258:15 amGNWForm 8.5 (EPT/RI) - De La Rue plc
27th Jan 20259:20 amGNWForm 8.5 (EPT/RI) - De La Rue plc
27th Jan 20259:16 amGNWForm 8.5 (EPT/RI) - Alliance Pharma plc
24th Jan 20258:21 amGNWForm 8.5 (EPT/RI) - Alliance Pharma plc
23rd Jan 20253:00 pmRNSPublication of a Prospectus
23rd Jan 20257:57 amGNWForm 8.5 (EPT/RI) - De La Rue plc
23rd Jan 20257:53 amGNWForm 8.5 (EPT/RI) - Alliance Pharma plc
22nd Jan 20258:40 amGNWForm 8.5 (EPT/RI) - Alliance Pharma plc
21st Jan 20258:10 amGNWForm 8.5 (EPT/RI) - De La Rue plc
21st Jan 20258:05 amGNWForm 8.5 (EPT/RI) - Alliance Pharma plc
20th Jan 20259:13 amGNWForm 8.5 (EPT/RI) - De La Rue plc
20th Jan 20258:38 amGNWForm 8.5 (EPT/RI) - Alliance Pharma plc
17th Jan 20259:37 amGNWForm 8.5 (EPT/RI)- Amendment of De La Rue plc
17th Jan 20259:20 amGNWForm 8.5 (EPT/RI)-De La Rue plc
17th Jan 20257:49 amGNWForm 8.5 (EPT/RI)-Alliance Pharma plc
16th Jan 20258:18 amGNWForm 8.5 (EPT/RI)-De La Rue plc
15th Jan 20258:53 amGNWForm 8.5 (EPT/RI)-Thruvision Group plc
15th Jan 20258:48 amGNWForm 8.5 (EPT/RI)-De La Rue plc
14th Jan 20259:34 amGNWForm 8.5 (EPT/RI)-De La Rue plc
14th Jan 20259:32 amGNWForm 8.5 (EPT/RI)-Alliance Pharma plc
13th Jan 20259:05 amGNWForm 8.5 (EPT/RI)- De La Rue plc
13th Jan 20259:02 amGNWForm 8.5 (EPT/RI)-Alliance Pharma plc
10th Jan 202510:46 amGNWForm 8.5 (EPT/RI)-De La Rue plc
9th Jan 20258:15 amGNWForm 8.5 (EPT/RI)-De La Rue plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.